PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Securities Purchase Agreement
DEFA14A: Others
8-K: Bionano Announces Preliminary 3Q 2024 Revenues and Cash
DEFA14A: Others
8-K: BioNano Genomics Restructures for Cost Efficiency and Cash Flow Optimization
DEFA14A: Others
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Securities Purchase Agreement
8-K: A Summary of the Matters Voted upon by Stockholders at the Annual Meeting
S-3: Registration statement for specified transactions by certain issuers
Bionano Genomics | 8-K: Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DEF 14A: Definitive information statements
DEFA14A: Others
Bionano Genomics | 8-K: Bionano Genomics Filed a Prospectus Supplement
Bionano Genomics | 8-K: Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
No Data
No Data